Drug Discovery by Targeting Mutant KRAS.

Ye, Na

Ye, Na.

Affiliation

Ye N; Department of Medicinal Chemistry College of Pharmaceutical Sciences SooChow University Suzhou, Jiangsu, 215123, China.

Curr Top Med Chem ; 19(23): 2079-2080, 2019.

Article in En | MEDLINE | ID: mdl-31762422

Subject(s)

Antineoplastic Agents/pharmacology; Drug Discovery; Mutation; Neoplasms/drug therapy; Neoplasms/genetics; Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors; Proto-Oncogene Proteins p21(ras)/genetics; Antineoplastic Agents/chemistry; Humans; Neoplasms/metabolism; Oncogene Protein p21(ras)/antagonists & inhibitors; Oncogene Protein p21(ras)/genetics; Oncogene Protein p21(ras)/metabolism; Proto-Oncogene Proteins p21(ras)/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Drug Discovery / Mutation / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Curr Top Med Chem Journal subject: QUIMICA Year: 2019 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google